Skip to content
Recall Observatory FDA recall evidence

Drug product

LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01

D-0150-2017

November 07, 2016

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 75691
Status
Terminated
Classification
Class II
Quantity
2,666 bottles
Official record key
drug-enforcement:D-0150-2017

Official wording

Reason: Superpotent

Code information: 16H21, Exp. 08/2017

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent